Gilead Sciences
Foster City · Founded 1987
About Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.
Company Facts
- Founded: 1987
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 10,001+
- Estimated revenue: $10M+
- Total funding: $4.4B
- Funding stage: IPO
- Last round: Post-IPO Debt (Nov 2024)
- Ticker: nasdaq:GILD
- Website: gilead.com
- Phone: 650-574-3000
Industries & Categories
Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/gilead-sciences-29520 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.